Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics. The lead drug is a formulation of doxorubicin, the ...
Parexo Labs, a division of Azaya, launches as a new CDMO with an emphasis on nanotechnology and liposomal manufacturing. Azaya Therapeutics, a biopharmaceutical company focused on focused on ...
BRIDGEPORT — A local man was sentenced Tuesday to 35 years in prison for fatally shooting the father of a 6-year-old girl behind an East Main Street apartment building two years ago. Azaya “Lil Zay” ...
Cytori Therapeutics said today it plans to acquire the liposomal nanoparticle technology platform of Azaya Therapeutics for up to $170 million, in a deal designed to expand and complement the buyer’s ...
Azaya Therapeutics Inc. expects to close this week on a $5 million bridge funding round . Azaya Therapeutics Inc. expects to close this week on a $5 million bridge funding round that the company ...
(Nanowerk News) A drug delivery system the size of a millionth of a centimeter could hold the key to more effective treatments of cancerous tumors. San Antonio researchers at the University of Texas ...
Cytori Therapeutics Inc. stock surged 7.9% to $1.78 per share in morning trade Thursday after the company said it had agreed to purchase assets from privately-held Azaya Therapeutics. Under the terms ...
SAN ANTONIO The National Cancer Institute has selected Azaya Therapeutics for a collaboration study of the company’s lead investigational cancer therapy, Azaya announced Monday. The studies, to be ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2026 American City Business Journals. All rights ...
Azaya Therapeutics, Inc. today announced the election of Dr. Ze’ev Shaked to its Board of Directors. Dr. Shaked has extensive managerial and pharmaceutical product development experience in ...
The acquisition of two partner-ready nanoparticle cancer candidates developed by Azaya Therapeutics Inc. and an associated nanotech platform could yield potential near-term revenue for Cytori ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results